Capital Expenditures - Ocugen Inc (NASDAQ:OCGN) - Alpha Spread

Ocugen Inc
NASDAQ:OCGN

Watchlist Manager
Ocugen Inc Logo
Ocugen Inc
NASDAQ:OCGN
Watchlist
Price: 1.145 USD 2.23% Market Closed
Market Cap: 294.7m USD
Have any thoughts about
Ocugen Inc?
Write Note

Ocugen Inc
Capital Expenditures

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Ocugen Inc
Capital Expenditures Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Capital Expenditures Analysis
Latest Figures & CAGR of Competitors

Company Capital Expenditures CAGR 3Y CAGR 5Y CAGR 10Y
Ocugen Inc
NASDAQ:OCGN
Capital Expenditures
-$9m
CAGR 3-Years
-124%
CAGR 5-Years
N/A
CAGR 10-Years
-33%
Abbvie Inc
NYSE:ABBV
Capital Expenditures
-$858m
CAGR 3-Years
1%
CAGR 5-Years
-6%
CAGR 10-Years
-4%
Gilead Sciences Inc
NASDAQ:GILD
Capital Expenditures
-$572m
CAGR 3-Years
3%
CAGR 5-Years
7%
CAGR 10-Years
-5%
Amgen Inc
NASDAQ:AMGN
Capital Expenditures
-$965m
CAGR 3-Years
-14%
CAGR 5-Years
-8%
CAGR 10-Years
-3%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Capital Expenditures
-$481.8m
CAGR 3-Years
-12%
CAGR 5-Years
-47%
CAGR 10-Years
-23%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Capital Expenditures
-$886.1m
CAGR 3-Years
-15%
CAGR 5-Years
-20%
CAGR 10-Years
-14%

See Also

What is Ocugen Inc's Capital Expenditures?
Capital Expenditures
-9m USD

Based on the financial report for Jun 30, 2024, Ocugen Inc's Capital Expenditures amounts to -9m USD.

What is Ocugen Inc's Capital Expenditures growth rate?
Capital Expenditures CAGR 10Y
-33%

Over the last year, the Capital Expenditures growth was -23%. The average annual Capital Expenditures growth rates for Ocugen Inc have been -124% over the past three years , and -33% over the past ten years .

Back to Top